+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Non-Adhesive Liquid Embolic Agents Market - Global Forecast 2026-2032- Product Image
Non-Adhesive Liquid Embolic Agents Market - Global Forecast 2026-2032- Product Image
Sale

Non-Adhesive Liquid Embolic Agents Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6153805
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Non-Adhesive Liquid Embolic Agents Market is projected to reach USD 1.81 Billion in 2026. It is expected to continue growing at a CAGR of 9.32%, reaching USD 3.08 Billion by 2032.

Non-Adhesive Liquid Embolic Agents: Executive Overview

Non-adhesive liquid embolic agents are injectable materials used to occlude targeted blood vessels without relying on a permanent adhesive bond to tissue. Their clinical relevance is concentrated in minimally invasive embolization procedures, including the management of vascular malformations, selected tumors, and other conditions requiring controlled vessel blockage. Adoption depends on evidence of safety and efficacy, catheter compatibility, operator experience, regulatory status, and the availability of interventional radiology and neurointerventional services.

Clinical Precision and Workflow Integration Are Reshaping Embolization

The field is being shaped by demand for more predictable delivery, controllable penetration, and reduced procedural trauma. Advances in catheter design, imaging guidance, injection techniques, and peri-procedural monitoring are improving physicians’ ability to target abnormal vasculature while limiting unintended embolization. At the same time, hospitals are emphasizing training, standardized protocols, and multidisciplinary case selection because outcomes depend on both agent characteristics and procedural expertise.

Artificial Intelligence Supports Planning, Guidance, and Follow-Up

Artificial intelligence is contributing to the broader embolization workflow through image segmentation, vascular-network visualization, case planning, and post-procedure assessment. Machine-learning tools may help identify relevant anatomy, quantify lesion characteristics, and flag changes during follow-up imaging, but their clinical value depends on validated datasets, integration with imaging platforms, and appropriate physician oversight. AI is therefore best viewed as a decision-support capability rather than a replacement for interventional judgment.

Regional Differences Reflect Infrastructure, Regulation, and Specialist Access

North America combines advanced interventional infrastructure with stringent evidence and regulatory expectations. Europe emphasizes harmonized clinical standards while retaining country-level differences in reimbursement and procurement. Asia-Pacific includes highly developed centers alongside rapidly expanding specialist capacity, creating varied access conditions. Latin America is influenced by public-private healthcare differences, import requirements, and uneven availability of advanced imaging. The Middle East is developing specialized centers, particularly in major urban systems, while Africa faces broader constraints in equipment, referral pathways, and specialist training. Across all regions, adoption is closely linked to catheterization facilities, imaging availability, reimbursement, and operator education.

Economic and Policy Groups Show Uneven Readiness for Advanced Embolization

ASEAN markets present diverse regulatory systems and healthcare capabilities, with leading urban centers generally better positioned to provide complex interventions. BRICS countries combine substantial clinical populations with differing levels of domestic manufacturing, specialist availability, and procurement capacity. The European Union benefits from regional regulatory coordination, although implementation and reimbursement remain nationally influenced. G7 members generally have mature interventional ecosystems and established clinical research networks. GCC states are investing in advanced hospital infrastructure and specialist services, while NATO members span highly developed systems and countries with more variable access to complex endovascular care.

Country-Level Priorities Range from Innovation Capacity to Access Expansion

Australia and Canada benefit from established specialist services but must address geographic concentration of care. Brazil and Mexico face regional disparities and procurement complexity. China and India have large and expanding interventional ecosystems, with continued emphasis on training, quality assurance, and access outside major cities. France, Germany, Italy, Spain, and the United Kingdom operate within sophisticated regulatory and clinical environments, while reimbursement, evidence requirements, and hospital purchasing processes differ. Japan and South Korea combine advanced imaging and procedural capabilities with aging-population needs. Russia’s access conditions are shaped by healthcare infrastructure, regulation, and supply considerations. In the United States, specialized centers support complex procedures, with adoption influenced by clinical evidence, hospital economics, coverage policies, and physician training.

Prioritize Evidence, Training, Compatibility, and Responsible Digital Integration

Industry leaders should build clinical evidence around clearly defined indications, procedural outcomes, and long-term safety. Product development should prioritize predictable injection behavior, visibility under imaging, catheter compatibility, and practical handling. Commercial and clinical strategies should be adapted to local regulatory and reimbursement requirements rather than treated as globally uniform. Providers should invest in structured physician training, simulation, proctoring, and multidisciplinary governance. Digital tools, including AI-enabled planning and follow-up, should be introduced with validation, cybersecurity controls, transparent performance monitoring, and clear accountability for clinical decisions.

Methodology for Assessing the Non-Adhesive Liquid Embolic Agents Landscape

This executive summary uses a structured qualitative assessment of the non-adhesive liquid embolic agent landscape. The analysis considers clinical applications, procedural workflows, enabling technologies, regulatory and reimbursement conditions, healthcare infrastructure, specialist availability, and regional differences. Geographic comparisons cover North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, alongside the specified economic and policy groups and countries. Findings are framed as evidence-based industry themes and do not constitute market estimates, forecasts, or investment advice.

Clinical Utility Will Depend on Reliable Outcomes and Equitable Delivery

Non-adhesive liquid embolic agents occupy an important role in image-guided vascular therapy, but their impact depends on more than material performance. Durable clinical evidence, careful patient selection, dependable delivery systems, skilled operators, and appropriate follow-up are central to responsible use. Regional infrastructure and policy conditions will continue to shape access, while AI and procedural innovation can improve planning and consistency when deployed with strong clinical governance. Leaders that align product development, education, evidence generation, and system-level implementation will be best positioned to support safe and effective adoption.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Non-Adhesive Liquid Embolic Agents Market, by Product Type
7.1. Introduction
7.2. Easyx
7.3. Onyx
7.4. Phil
7.5. Squid
8. Non-Adhesive Liquid Embolic Agents Market, by Application
8.1. Introduction
8.2. Arteriovenous Malformation
8.3. Cerebral Aneurysm
8.4. Endoleak
8.5. Peripheral Vascular Malformation
9. Non-Adhesive Liquid Embolic Agents Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Hospitals
9.4. Specialized Vascular Clinics
10. Non-Adhesive Liquid Embolic Agents Market, by Distribution Channel
10.1. Introduction
10.2. Direct Sales
10.3. Distributors
11. Non-Adhesive Liquid Embolic Agents Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Non-Adhesive Liquid Embolic Agents Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Non-Adhesive Liquid Embolic Agents Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. ABBOTT Laboratories
15.2. Arterial Therapeutics, Inc.
15.3. B. Braun SE
15.4. Balt Extrusion SAS
15.5. BlackSwan Vascular Inc.
15.6. Boston Scientific Corporation
15.7. Cerenovus LLC
15.8. Cook Medical LLC
15.9. Cordis Corporation
15.10. Endovascular Technologies, Inc.
15.11. equinox Vascular LLC
15.12. GEM S.r.l.
15.13. INVAMED Research & Development Inc.
15.14. Johnson & Johnson
15.15. Medtronic plc
15.16. Meril Life Sciences Pvt. Ltd.
15.17. MicroVention, Inc.
15.18. Micrus Endovascular Corporation
15.19. Neuravi Ltd.
15.20. Philips Healthcare
15.21. Sirtex Medical Limited
15.22. Smith & Nephew Plc
15.23. Stryker Corporation
15.24. Success Bio-Tech Co., Ltd.
15.25. Terumo Corporation
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Non-Adhesive Liquid Embolic Agents Market, Years Considered for the Study
FIGURE 2. Global Non-Adhesive Liquid Embolic Agents Market, Research Design
FIGURE 3. Global Non-Adhesive Liquid Embolic Agents Market, Research Framework
FIGURE 4. Global Non-Adhesive Liquid Embolic Agents Market, Data Triangulation
FIGURE 5. Global Non-Adhesive Liquid Embolic Agents Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Non-Adhesive Liquid Embolic Agents Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Non-Adhesive Liquid Embolic Agents Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Non-Adhesive Liquid Embolic Agents Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Non-Adhesive Liquid Embolic Agents Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Non-Adhesive Liquid Embolic Agents Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Non-Adhesive Liquid Embolic Agents Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Non-Adhesive Liquid Embolic Agents Market Segmentation & Coverage
TABLE 2. Global Non-Adhesive Liquid Embolic Agents Market Size, 2017-2032 (USD Million)
TABLE 3. Global Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Easyx Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Easyx Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Easyx Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Onyx Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Onyx Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Onyx Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Phil Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Phil Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Phil Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Squid Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Squid Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Squid Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 17. Global Arteriovenous Malformation Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Arteriovenous Malformation Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Arteriovenous Malformation Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Cerebral Aneurysm Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Cerebral Aneurysm Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Cerebral Aneurysm Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Endoleak Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Endoleak Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Endoleak Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Peripheral Vascular Malformation Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Peripheral Vascular Malformation Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Peripheral Vascular Malformation Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 30. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Specialized Vascular Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Specialized Vascular Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Specialized Vascular Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 40. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Non-Adhesive Liquid Embolic Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Asia-Pacific Non-Adhesive Liquid Embolic Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Asia-Pacific Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 49. Asia-Pacific Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 50. Asia-Pacific Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 51. Asia-Pacific Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 52. North America Non-Adhesive Liquid Embolic Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. North America Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 54. North America Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 55. North America Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 56. North America Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 57. Latin America Non-Adhesive Liquid Embolic Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Latin America Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 59. Latin America Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 60. Latin America Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 61. Latin America Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 62. Europe Non-Adhesive Liquid Embolic Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Europe Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 64. Europe Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 65. Europe Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 66. Europe Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 67. Middle East Non-Adhesive Liquid Embolic Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Middle East Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 69. Middle East Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 70. Middle East Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. Middle East Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 72. Africa Non-Adhesive Liquid Embolic Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Africa Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 74. Africa Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 75. Africa Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 76. Africa Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 77. Global Non-Adhesive Liquid Embolic Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. ASEAN Non-Adhesive Liquid Embolic Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. ASEAN Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 80. ASEAN Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 81. ASEAN Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 82. ASEAN Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 83. GCC Non-Adhesive Liquid Embolic Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. GCC Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 85. GCC Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 86. GCC Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 87. GCC Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 88. European Union Non-Adhesive Liquid Embolic Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. European Union Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 90. European Union Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 91. European Union Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. European Union Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 93. BRICS Non-Adhesive Liquid Embolic Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. BRICS Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 95. BRICS Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 96. BRICS Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. BRICS Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 98. G7 Non-Adhesive Liquid Embolic Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. G7 Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 100. G7 Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 101. G7 Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. G7 Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 103. NATO Non-Adhesive Liquid Embolic Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. NATO Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 105. NATO Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 106. NATO Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. NATO Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 108. Global Non-Adhesive Liquid Embolic Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. United States Non-Adhesive Liquid Embolic Agents Market Size, 2017-2032 (USD Million)
TABLE 110. United States Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 111. United States Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 112. United States Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. United States Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 114. Canada Non-Adhesive Liquid Embolic Agents Market Size, 2017-2032 (USD Million)
TABLE 115. Canada Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 116. Canada Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. Canada Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 118. Canada Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 119. Mexico Non-Adhesive Liquid Embolic Agents Market Size, 2017-2032 (USD Million)
TABLE 120. Mexico Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 121. Mexico Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. Mexico Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. Mexico Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 124. Brazil Non-Adhesive Liquid Embolic Agents Market Size, 2017-2032 (USD Million)
TABLE 125. Brazil Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 126. Brazil Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 127. Brazil Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. Brazil Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 129. United Kingdom Non-Adhesive Liquid Embolic Agents Market Size, 2017-2032 (USD Million)
TABLE 130. United Kingdom Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 131. United Kingdom Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. United Kingdom Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. United Kingdom Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 134. Germany Non-Adhesive Liquid Embolic Agents Market Size, 2017-2032 (USD Million)
TABLE 135. Germany Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 136. Germany Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. Germany Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. Germany Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 139. France Non-Adhesive Liquid Embolic Agents Market Size, 2017-2032 (USD Million)
TABLE 140. France Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 141. France Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 142. France Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. France Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 144. Russia Non-Adhesive Liquid Embolic Agents Market Size, 2017-2032 (USD Million)
TABLE 145. Russia Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 146. Russia Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 147. Russia Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. Russia Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 149. Italy Non-Adhesive Liquid Embolic Agents Market Size, 2017-2032 (USD Million)
TABLE 150. Italy Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 151. Italy Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 152. Italy Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. Italy Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 154. Spain Non-Adhesive Liquid Embolic Agents Market Size, 2017-2032 (USD Million)
TABLE 155. Spain Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 156. Spain Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. Spain Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. Spain Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 159. China Non-Adhesive Liquid Embolic Agents Market Size, 2017-2032 (USD Million)
TABLE 160. China Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 161. China Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. China Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. China Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 164. India Non-Adhesive Liquid Embolic Agents Market Size, 2017-2032 (USD Million)
TABLE 165. India Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 166. India Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 167. India Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. India Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 169. Japan Non-Adhesive Liquid Embolic Agents Market Size, 2017-2032 (USD Million)
TABLE 170. Japan Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 171. Japan Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 172. Japan Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. Japan Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 174. Australia Non-Adhesive Liquid Embolic Agents Market Size, 2017-2032 (USD Million)
TABLE 175. Australia Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 176. Australia Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. Australia Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Australia Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 179. South Korea Non-Adhesive Liquid Embolic Agents Market Size, 2017-2032 (USD Million)
TABLE 180. South Korea Non-Adhesive Liquid Embolic Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 181. South Korea Non-Adhesive Liquid Embolic Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. South Korea Non-Adhesive Liquid Embolic Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. South Korea Non-Adhesive Liquid Embolic Agents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 184. Global Non-Adhesive Liquid Embolic Agents Market Share, by Key Player, 2025
TABLE 185. Global Non-Adhesive Liquid Embolic Agents Market, Key Experts

Companies Mentioned

  • ABBOTT Laboratories
  • Arterial Therapeutics, Inc.
  • B. Braun SE
  • Balt Extrusion SAS
  • BlackSwan Vascular Inc.
  • Boston Scientific Corporation
  • Cerenovus LLC
  • Cook Medical LLC
  • Cordis Corporation
  • Endovascular Technologies, Inc.
  • equinox Vascular LLC
  • GEM S.r.l.
  • INVAMED Research & Development Inc.
  • Johnson & Johnson
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroVention, Inc.
  • Micrus Endovascular Corporation
  • Neuravi Ltd.
  • Philips Healthcare
  • Sirtex Medical Limited
  • Smith & Nephew Plc
  • Stryker Corporation
  • Success Bio‑Tech Co., Ltd.
  • Terumo Corporation

Related Topics

Related Reports

Peripheral Liquid Embolic Agents - Global Strategic Business Report - Product Image

Peripheral Liquid Embolic Agents - Global Strategic Business Report

  • Report
  • 460 Pages
  • Global
From
Liquid Electrical Adhesive Market - Global Forecast 2026-2032 - Product Image

Liquid Electrical Adhesive Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Liquid Adhesives Market - Global Forecast 2026-2032 - Product Image

Liquid Adhesives Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Textile Adhesive Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Textile Adhesive Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Acrylic Resin Hotmelt Adhesive Agents Market - Global Strategic Business Report - Product Image

Acrylic Resin Hotmelt Adhesive Agents Market - Global Strategic Business Report

  • Report
  • 294 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.